{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:05Z","timestamp":1786119305551,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,15]]},"DOI":"10.1097\/tp.0b013e3181adcae6","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T03:34:04Z","timestamp":1249356844000},"page":"303-307","source":"Crossref","is-referenced-by-count":100,"title":["Rituximab, IVIG, and Plasma Exchange Without Graft Local Infusion Treatment: A New Protocol in ABO Incompatible Living Donor Liver Transplantation"],"prefix":"10.1097","volume":"88","author":[{"given":"Toru","family":"Ikegami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/TP.0b013e3181943d46","article-title":"Donor risk in adult-to-adult living donor liver transplantation: Impact of left lobe graft.","volume":"87","author":"Taketomi","year":"2009","journal-title":"Transplantation"},{"key":"R2-4-20210211","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00007890-200206270-00021","article-title":"Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation.","volume":"73","author":"Tanabe","year":"2002","journal-title":"Transplantation"},{"key":"R3-4-20210211","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1744-9987.2006.00409.x","article-title":"The role of apheresis therapy for ABO incompatible living donor liver transplantation: The Kyoto University experience.","volume":"10","author":"Kozaki","year":"2006","journal-title":"Ther Apher Dial"},{"key":"R4-4-20210211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-0012.2006.00572.x","article-title":"Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.","volume":"21","author":"Usui","year":"2007","journal-title":"Clin Transplant"},{"key":"R5-4-20210211","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/01.TP.0000137264.99113.2B","article-title":"Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis.","volume":"78","author":"Morioka","year":"2004","journal-title":"Transplantation"},{"key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00534-007-1298-2","article-title":"Current status of liver transplantation across ABO blood-type barrier.","volume":"15","author":"Egawa","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan.","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.transproceed.2007.09.028","article-title":"Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin.","volume":"39","author":"Ikegami","year":"2007","journal-title":"Transplant Proc"},{"key":"R9-4-20210211","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1600-6143.2006.01284.x","article-title":"Feasibility of left lobe living donor liver transplantation between adults: An 8-year, single-center experience of 107 cases.","volume":"6","author":"Soejima","year":"2006","journal-title":"Am J Transplant"},{"key":"R10-4-20210211","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/01.tp.0000296483.89112.4c","article-title":"Explanted portal vein grafts for middle hepatic vein tributaries in living-donor liver transplantation.","volume":"84","author":"Ikegami","year":"2007","journal-title":"Transplantation"},{"key":"R11-4-20210211","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1432-2277.2005.00159.x","article-title":"Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation.","volume":"18","author":"Suehiro","year":"2005","journal-title":"Transpl Int"},{"key":"R12-4-20210211","first-page":"489","article-title":"Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers.","volume":"132","author":"Demetris","year":"1988","journal-title":"Am J Pathol"},{"key":"R13-4-20210211","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","article-title":"B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.","volume":"13","author":"Egawa","year":"2007","journal-title":"Liver Transpl"},{"key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-6143.2005.01214.x","article-title":"Intravenous gammaglobulin (IVIG): A novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.","volume":"6","author":"Jordan","year":"2006","journal-title":"Am J Transplant"},{"key":"R15-4-20210211","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1600-6143.2004.00507.x","article-title":"Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy.","volume":"4","author":"Sonnenday","year":"2004","journal-title":"Am J Transplant"},{"key":"R16-4-20210211","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1034\/j.1600-6143.2003.00121.x","article-title":"Utility of intravenous immune globulin in kidney transplantation: Efficacy, safety, and cost implications.","volume":"3","author":"Jordan","year":"2003","journal-title":"Am J Transplant"},{"key":"R17-4-20210211","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action.","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"R18-4-20210211","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1432-2277.2008.00678.x","article-title":"The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft.","volume":"21","author":"Yoshizumi","year":"2008","journal-title":"Transpl Int"},{"key":"R19-4-20210211","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jamcollsurg.2008.10.034","article-title":"Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension.","volume":"208","author":"Ikegami","year":"2009","journal-title":"J Am Coll Surg"},{"key":"R20-4-20210211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jca.20156","article-title":"The role of immunomodulation in ABO-incompatible adult liver transplant recipients.","volume":"23","author":"Urbani","year":"2008","journal-title":"J Clin Apher"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181adcae6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:45Z","timestamp":1786039245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200908150-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,15]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181adcae6","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,15]]}}}